Cite
Peripheral lymphocyte fluctuation as an indicator of severe immune-related adverse events in patients treated with immune checkpoint inhibitors.
MLA
Haraguchi, Masafumi, et al. “Peripheral Lymphocyte Fluctuation as an Indicator of Severe Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors.” Cancer Medicine, vol. 12, no. 9, May 2023, pp. 10636–46. EBSCOhost, https://doi.org/10.1002/cam4.5816.
APA
Haraguchi, M., Nakao, Y., Narita, S., Matsumoto, K., Fukushima, M., Sasaki, R., Honda, T., Miuma, S., Miyaaki, H., & Nakao, K. (2023). Peripheral lymphocyte fluctuation as an indicator of severe immune-related adverse events in patients treated with immune checkpoint inhibitors. Cancer Medicine, 12(9), 10636–10646. https://doi.org/10.1002/cam4.5816
Chicago
Haraguchi, Masafumi, Yasuhiko Nakao, Syouhei Narita, Kousuke Matsumoto, Masanori Fukushima, Ryu Sasaki, Takuya Honda, Satoshi Miuma, Hisamitsu Miyaaki, and Kazuhiko Nakao. 2023. “Peripheral Lymphocyte Fluctuation as an Indicator of Severe Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitors.” Cancer Medicine 12 (9): 10636–46. doi:10.1002/cam4.5816.